Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon C Jayson

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Nature Reviews. Clinical Oncology|February 15, 2012
Antiangiogenic therapy--evolving view based on clinical trial resultsGordon C Jayson, Daniel J Hicklin, Lee M Ellis
BMC Nephrology|October 24, 2019
Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort studyRajkumar Chinnadurai, Emma Flanagan, Gordon C Jayson, et al.
The Journal of Biological Chemistry|February 25, 2014
Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signalingClaire L Cole, Graham Rushton, Gordon C Jayson, et al.
The Lancet. Oncology|May 4, 2010
The ethical and scientific case for phase 2C clinical trialsYing-Kiat Zee, Sarah W Chan, John Harris, et al.
Current Opinion in Oncology|September 1, 2007
Antiangiogenic therapy for ovarian cancerDaniela D Rosa, Andrew R Clamp, Fiona Collinson, et al.
Lancet (London, England)|February 9, 2016
Antiangiogenic therapy in oncology: current status and future directionsGordon C Jayson, Robert Kerbel, Lee M Ellis, et al.
Organic Letters|December 18, 2012
First gram-scale synthesis of a heparin-related dodecasaccharideSteen U Hansen, Gavin J Miller, Gordon C Jayson, et al.
British Journal of Cancer|October 30, 2021
The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancerAlexander D Murphy, Robert D Morgan, Andrew R Clamp, et al.
Lancet (London, England)|April 29, 2014
Ovarian cancerGordon C Jayson, Elise C Kohn, Henry C Kitchener, et al.
The Journal of Organic Chemistry|March 22, 2016
An Updated Synthesis of the Diazo-Transfer Reagent Imidazole-1-sulfonyl Azide Hydrogen SulfateGarrett T Potter, Gordon C Jayson, Gavin J Miller, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Nature Reviews. Clinical Oncology|February 15, 2012
Antiangiogenic therapy--evolving view based on clinical trial resultsGordon C Jayson, Daniel J Hicklin, Lee M Ellis
BMC Nephrology|October 24, 2019
Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort studyRajkumar Chinnadurai, Emma Flanagan, Gordon C Jayson, et al.
The Journal of Biological Chemistry|February 25, 2014
Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signalingClaire L Cole, Graham Rushton, Gordon C Jayson, et al.
The Lancet. Oncology|May 4, 2010
The ethical and scientific case for phase 2C clinical trialsYing-Kiat Zee, Sarah W Chan, John Harris, et al.
Current Opinion in Oncology|September 1, 2007
Antiangiogenic therapy for ovarian cancerDaniela D Rosa, Andrew R Clamp, Fiona Collinson, et al.
Lancet (London, England)|February 9, 2016
Antiangiogenic therapy in oncology: current status and future directionsGordon C Jayson, Robert Kerbel, Lee M Ellis, et al.
Organic Letters|December 18, 2012
First gram-scale synthesis of a heparin-related dodecasaccharideSteen U Hansen, Gavin J Miller, Gordon C Jayson, et al.
British Journal of Cancer|October 30, 2021
The role of vascular endothelial growth factor inhibitors in the treatment of epithelial ovarian cancerAlexander D Murphy, Robert D Morgan, Andrew R Clamp, et al.
Lancet (London, England)|April 29, 2014
Ovarian cancerGordon C Jayson, Elise C Kohn, Henry C Kitchener, et al.
The Journal of Organic Chemistry|March 22, 2016
An Updated Synthesis of the Diazo-Transfer Reagent Imidazole-1-sulfonyl Azide Hydrogen SulfateGarrett T Potter, Gordon C Jayson, Gavin J Miller, et al.
Pageof 13